Literature DB >> 8551655

Percutaneous endoscopic gastrojejunostomy: a dual center safety and efficacy trial.

M H DeLegge1, P F Duckworth, L McHenry, A Foxx-Orenstein, R M Craig, D F Kirby.   

Abstract

Although jejunal tube placement through a percutaneous endoscopic gastrostomy (PEG) has not been proven to be preferable to PEG feeding, it would be theoretically advantageous for those patients prone to gastrointestinal aspiration. However, reliable placement of a small bowel feeding tube through a PEG has been technically difficult. We have previously reported successful placement of a percutaneous endoscopic gastrojejunostomy (PEG/J) with minimal complications. These results are in contrast to other series that report technical difficulty, frequent tube dysfunction and gastric aspiration. We describe an over-the-wire PEG/J technique performed by multiple operators at two medical centers. Gastrostomy tube placement was successful in 94% of patients. Initial placement of the jejunal tube was successful in 88% of patients. Second attempts were 100% successful. The average procedure time was 36 minutes. The distal duodenal and jejunal placement of the jejunal tube resulted in no episodes of gastroduodenal reflux. Complications included jejunal tube migration (6%), clogging (18%), and unintentional removal (11%). The majority of patients were ultimately converted to either oral or intragastric feedings. We conclude that the PEG/J system is a reliable, reproducible method of small bowel feeding and is associated with no episodes of tube feeding reflux when the jejunal tube is positioned in the distal duodenum or beyond. Furthermore, it provides a temporary nutritional bridge for those patients who are later transitioned to either PEG or oral feeding.

Entities:  

Mesh:

Year:  1995        PMID: 8551655     DOI: 10.1177/0148607195019003239

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  8 in total

Review 1.  Enteral nutrition access devices.

Authors:  A Habib; D F Kirby
Journal:  Curr Gastroenterol Rep       Date:  1999-08

2.  Enteral access by double-balloon enteroscopy: an alternative method of direct percutaneous endoscopic jejunostomy placement.

Authors:  E J Despott; S Gabe; E Tripoli; K Konieczko; C Fraser
Journal:  Dig Dis Sci       Date:  2010-06-29       Impact factor: 3.199

3.  The use of enteral access for continuous delivery of levodopa-carbidopa in patients with advanced Parkinson's disease.

Authors:  Julian Cheron; Jacques Deviere; Frederic Supiot; Asuncion Ballarin; Pierre Eisendrath; Emmanuel Toussaint; Vincent Huberty; Carmen Musala; Daniel Blero; Arnaud Lemmers; André Van Gossum; Marianna Arvanitakis
Journal:  United European Gastroenterol J       Date:  2016-06-23       Impact factor: 4.623

Review 4.  Post-pyloric feeding.

Authors:  Eva Niv; Zvi Fireman; Nachum Vaisman
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

5.  Does the presence of esophagitis prior to PEG placement increase the risk for aspiration pneumonia?

Authors:  Matthew L Carnes; David A Sabol; Mark DeLegge
Journal:  Dig Dis Sci       Date:  2004 Nov-Dec       Impact factor: 3.199

6.  Comparison of laparoscopic jejunostomy tube to percutaneous endoscopic gastrostomy tube with jejunal extension: long-term durability and nutritional outcomes.

Authors:  Ivy N Haskins; Andrew T Strong; Mary Baginsky; Gautam Sharma; Matthew Karafa; Jeffrey L Ponsky; John H Rodriguez; Matthew D Kroh
Journal:  Surg Endosc       Date:  2017-12-07       Impact factor: 4.584

Review 7.  Enteral nutrition in intensive care patients: a practical approach. Working Group on Nutrition and Metabolism, ESICM. European Society of Intensive Care Medicine.

Authors:  P Jolliet; C Pichard; G Biolo; R Chioléro; G Grimble; X Leverve; G Nitenberg; I Novak; M Planas; J C Preiser; E Roth; A M Schols; J Wernerman
Journal:  Intensive Care Med       Date:  1998-08       Impact factor: 17.440

8.  The impact of tube replacement timing during LCIG therapy on PEG-J associated adverse events: a retrospective multicenter observational study.

Authors:  Kanefumi Yamashita; Yukinori Yube; Yukinao Yamazaki; Takehide Fukuchi; Masaki Kato; Tomoyuki Koike; Takeshi Uehara; Yoshiou Ikeda; Satoshi Furune; Hidehiro Murakami; Eiji Kubota; Shinsuke Fujioka; Yoshinori Sato; Xiaoyi Jin; Tomohiko Suzuki; Kazuhiro Furukawa; Yoshio Tsuboi
Journal:  BMC Neurol       Date:  2021-06-25       Impact factor: 2.474

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.